Hakutulokset - Hans Gelderblom

Tarkenna hakua
  1. 1
    Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series

    Pneumothorax as adverse event in patients with lung metastases of soft tissue sarcoma treated with pazopanib: a single reference centre case series Tekijä Arie J. Verschoor, Hans Gelderblom

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Osteosarcoma: Evolution of Treatment Paradigms

    Osteosarcoma: Evolution of Treatment Paradigms Tekijä Norman Jaffe, Ajay Puri, Hans Gelderblom

    Julkaistu 2013
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    The Structure of Group II Adenoviruses

    The Structure of Group II Adenoviruses Tekijä Hans Gelderblom, Heinz Bauer, H. Frank

    Julkaistu 1967
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone

    Challenges of denosumab in giant cell tumor of bone, and other giant cell-rich tumors of bone Tekijä Astrid Lipplaa, P. D. S. Dijkstra, Hans Gelderblom

    Julkaistu 2019
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome

    Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome Tekijä Ellen Kapiteijn, Anneke Brand, Judith R. Kroep, Hans Gelderblom

    Julkaistu 2007
    Hae kokoteksti Hae kokoteksti
    Carta
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    MHC-Antigens: Constituents of the Envelopes of Human and Simian Immunodeficiency

    MHC-Antigens: Constituents of the Envelopes of Human and Simian Immunodeficiency Tekijä Hans Gelderblom, Hilmar Reupke, Thorsten Winkel, R. Kunze, Georg Pauli

    Julkaistu 1987
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline

    RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline Tekijä Els L. van Persijn van Meerten, Hans Gelderblom, Johan L. Bloem

    Julkaistu 2009
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time

    Pre-therapeutic UGT1A1 genotyping to reduce the risk of irinotecan-induced severe toxicity: Ready for prime time Tekijä Emma C. Hulshof, Maarten J. Deenen, Henk‐Jan Guchelaar, Hans Gelderblom

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens

    Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens Tekijä Jeroen S. Kloover, Michael A. den Bakker, Hans Gelderblom, Jan P. van Meerbeeck

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction

    Herpesvirus type 6 in patients undergoing bone marrow transplantation: serologic features and detection by polymerase chain reaction Tekijä Freimut Wilborn, Volker Brinkmann, CA Schmidt, F Neipel, Hans Gelderblom, W. Siegert

    Julkaistu 1994
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Prognostic factors for survival in Ewing sarcoma: A systematic review

    Prognostic factors for survival in Ewing sarcoma: A systematic review Tekijä Sarah E. Bosma, Onarisa Ayu, Marta Fiocco, Hans Gelderblom, P. D. S. Dijkstra

    Julkaistu 2018
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Quantification of sunitinib in human plasma by high-performance liquid chromatography–tandem mass spectrometry☆

    Quantification of sunitinib in human plasma by high-performance liquid chromatography–tandem mass spectrometry☆ Tekijä Patton Minkin, Ming Zhao, Z CHEN, Jannemieke Ouwerkerk, Hans Gelderblom, Sharyn D. Baker

    Julkaistu 2008
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review

    Concordance of Predictive Markers for EGFR Inhibitors in Primary Tumors and Metastases in Colorectal Cancer: A Review Tekijä Jara M. Baas, L. L. Krens, Henk‐Jan Guchelaar, Hans Morreau, Hans Gelderblom

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Tekijä Alfredo Berruti, Eric Baudin, Hans Gelderblom, Harm R. Haak, F. Porpiglia, Martin Faßnacht, G. Pentheroudakis

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    The Impact of Chemotherapy and Body Mass Index on Cancer‐Related Fatigue in Colon Cancer Patients: A <scp>PROFILES</scp>‐Registry Study

    The Impact of Chemotherapy and Body Mass Index on Cancer‐Related Fatigue in Colon Cancer Patients: A <scp>PROFILES</scp>‐Registry Study Tekijä Anneke Kastelein, Floortje Mols, Laura Kervezee, Niels H. Chavannes, Hans Gelderblom, Jacques Neefjes, Chris Hinnen

    Julkaistu 2025
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    New treatment modalities in advanced thyroid cancer

    New treatment modalities in advanced thyroid cancer Tekijä Ellen Kapiteijn, Tatiana Schneider, Hans Morreau, Hans Gelderblom, J.W.R. Nortier, Johannes W. A. Smit

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study

    The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study Tekijä Arie J. Verschoor, Judith V.M.G. Bovée, Lucy Overbeek, Pancras C.W. Hogendoorn, Hans Gelderblom

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options?

    Individualized Dosing of Fluoropyrimidine‐Based Chemotherapy to Prevent Severe Fluoropyrimidine‐Related Toxicity: What Are the Options? Tekijä Jonathan E. Knikman, Hans Gelderblom, Jos H. Beijnen, Annemieke Cats, Henk‐Jan Guchelaar, Linda M. Henricks

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia.

    Expression of proteins encoded by Epstein-Barr virus trans-activator genes depends on the differentiation of epithelial cells in oral hairy leukoplakia. Tekijä Jürgen C. Becker, Ulrike Leser, Manfred Marschall, A. Langford, Wolfgang Jilg, Hans Gelderblom, P. A. Reichart, Hans Wolf

    Julkaistu 1991
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics

    Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics Tekijä Dyah Aryani Perwitasari, Hans Gelderblom, Jarir At Thobari, Mustofa Mustofa, Iwan Dwiprahasto, J.W.R. Nortier, Henk‐Jan Guchelaar

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: